Premier Alternatives

Lumen Bioscience

Seattle, WA · Founded 2017 · Privately Held (backing)

Operator of a biosciences company intended to develop biologic drugs faster than traditional ways. Lumen Bioscience is based in Seattle, WA and was founded in 2017. Its last reported valuation was $92.8 million in Sep 2020. It has raised $111 million.

Last reported valuation
$92.8M
Oct 2026
Priced at
—
Total raised
$111.0M
Last round
—

Lumen Bioscience key facts

as of Oct 2026
  • Operator of a biosciences company intended to develop biologic drugs faster than traditional ways.
  • Lumen Bioscience is valued at approximately $92.8M as of Oct 2026 (last reported valuation).
  • It has raised $111.0M; the latest was Later Stage VC ($30.0M) in Oct 2025.
  • Notable investors include U.S. Department of Energy, National Institutes of Health, Gates Foundation, United States Department of Agriculture, CARB-X — 18 tracked in total.
  • Lumen Bioscience has filed 5 Form Ds with the SEC since 2019, most recently Apr 2025 ( sold).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$92.8M

Lumen Bioscience's last reported valuation, Sep 2020. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Lumen Bioscience with a free account
  • ·The complete investor list: 18 names
  • ·Watch Lumen Bioscience: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Lumen Bioscience funding rounds

No rounds on record

No funding rounds for Lumen Bioscience are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Lumen Bioscience valuation

Lumen Bioscience's last reported valuation was $92.8 million in Sep 2020. No priced round, secondary trade or fund mark has surfaced since.

How much has Lumen Bioscience raised?

Lumen Bioscience has filed 5 Form Ds with the SEC since 2019, most recently in Apr 2025 (null sold).

Lumen Bioscience investors

18 investors are on record for Lumen Bioscience, including U.S. Department of Energy, National Institutes of Health, Gates Foundation and United States Department of Agriculture.

About Lumen Bioscience

Operator of a biosciences company intended to develop biologic drugs faster than traditional ways. The company discovers, and develops biological drugs for several prevalent, worldwide diseases that currently lack any effective treatments through technology that increases speed, mass-market scale and lower costs than current approaches, enabling clinicians to have access to innovative treatments for ailments currently lacking effective options.

Sector
Healthcare
HQ
Seattle, WA, United States
Founded
2017
Employees
101
Website
lumen.bio/
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.